London, England, United Kingdom In 2002 was created F2 Ventures, which is appeared as VC. The main office of represented VC is situated in the London. The fund was located in Europe if to be more exact in United Kingdom.
Among the various public portfolio startups of the fund, we may underline AlloVir, Cullinan Oncology, Cullinan Oncology Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Pharmaceutical, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the F2 Ventures, startups are often financed by New York Angels, MPM Capital, Jerusalem Global Ventures. The meaningful sponsors for the fund in investment in the same round are MPM Capital, UBS Asset Management, Redmile Group. In the next rounds fund is usually obtained by Venturra Capital, MPM Capital, Cento Ventures.
We also calculated 1 valuable employee in our database.
Comparing to the other companies, this F2 Ventures performs on 12 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2019. The important activity for fund was in 2015.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AIP Private Markets | - |
| Aligo Innovation | Canada, Montréal, Quebec |
| Danone | France, Ile-de-France, Paris |
| Fair by Design Fund | England, London, United Kingdom |
| Gardiner Group Capital | Canada, Ontario, Toronto |
| Hikari Tsushin Group | Chiyoda, Japan |
| Hokuriku Bank | Japan, Toyama, Toyama Prefecture |
| Huiruying Investment | China, Guangdong Province, Huizhou |
| Jianxing Medical Fund | China, Jianxing, Sichuan |
| Kilowatt Capital LLC | California, San Francisco, United States |
| Mazor Robotics | Caesarea, Hefa, Israel |
| Metdist | England, London, United Kingdom |
| Millennium Life Sciences Fund | Anaheim, California, United States |
| Network Solutions | Herndon, United States, Virginia |
| Nordstjernan | Stockholm, Stockholm County, Sweden |
| NTT-ME | Japan, Toshima |
| TowerJazz | Israel, Migdal Haemeq, North District |
| Yeling Chuangye Touzi | Baoshan, China, Shanghai |
| Zhejiang Haining Yingchuang Equity Investment | China, Haining, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ReNAgade Therapeutics | $300M | 23 May 2023 | Cambridge, Massachusetts, United States | ||
4M Analytics | $30M | 20 Sep 2022 | Herzliya, Tel Aviv, Israel | ||
Justt | $70M | 16 Nov 2021 | Tel Aviv, Tel Aviv, Israel | ||
Five Sigma | $12M | 13 Sep 2021 | Tel Aviv, Tel Aviv, Israel | ||
4M Analytics | $11M | 09 Aug 2021 | Herzliya, Tel Aviv, Israel | ||
ElevateBio | $525M | 15 Mar 2021 | Cambridge, Massachusetts, United States | ||
| $80M | 24 Feb 2021 | Cambridge, Massachusetts, United States | |||
Cullinan Oncology | $131M | 17 Dec 2020 | Cambridge, Massachusetts, United States | ||
Cullinan Oncology | $98M | 04 Jun 2020 | Cambridge, Massachusetts, United States |
– Parametrix, a startup that offers insurance policies for companies that rely on third-party cloud providers, e-commerce services, payment gateways and CRM systems, raised $17.5m funding.
– The round was led by FirstMark Capital and F2 Venture Capital.
– The company offers insurance policies for companies that rely on third-party cloud providers, e-commerce services, payment gateways and CRM systems.
– It offers insurance policies for companies that rely on third-party cloud providers, e-commerce services, payment gateways and CRM systems.
– ElevateBio is a Cambridge, Mass.-based cell and gene therapy technology company focused on advancing new cell and gene therapies.
– Company raised $525m in Series C funding.
– The round was led by Matrix Capital Management with participation from new investors SoftBank Vision Fund 2 and Fidelity Management and Research Company and existing investors MPM Capital, F2 Ventures, Redmile Group, EcoR1 Capital, Samsara BioCapital, The Invus Group, Emerson Collective, Surveyor Capital (A Citadel company), EDBI, and Vertex Ventures, iTochu, and a large insurance company.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ReNAgade Therapeutics | $300M | 23 May 2023 | Cambridge, Massachusetts, United States | ||
4M Analytics | $30M | 20 Sep 2022 | Herzliya, Tel Aviv, Israel | ||
Justt | $70M | 16 Nov 2021 | Tel Aviv, Tel Aviv, Israel | ||
Five Sigma | $12M | 13 Sep 2021 | Tel Aviv, Tel Aviv, Israel | ||
4M Analytics | $11M | 09 Aug 2021 | Herzliya, Tel Aviv, Israel | ||
ElevateBio | $525M | 15 Mar 2021 | Cambridge, Massachusetts, United States | ||
| $80M | 24 Feb 2021 | Cambridge, Massachusetts, United States | |||
Cullinan Oncology | $131M | 17 Dec 2020 | Cambridge, Massachusetts, United States | ||
Cullinan Oncology | $98M | 04 Jun 2020 | Cambridge, Massachusetts, United States |
